Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-015399
Filing Date
2024-01-25
Accepted
2024-01-25 16:09:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 91797
2 GRAPHIC g530411dsp1.jpg GRAPHIC 8542
3 GRAPHIC g530411dsp1a.jpg GRAPHIC 7863
  Complete submission text file 0001193125-24-015399.txt   115657
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)